Marketable Securities, Current in USD of Unity Biotechnology, Inc. from Q4 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Unity Biotechnology, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2017 to Q1 2025.
  • Unity Biotechnology, Inc. Marketable Securities, Current for the quarter ending 31 Mar 2025 was $8.93M, a 69.1% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $8.93M -$20M -69.1% 31 Mar 2025 10-Q 22 Apr 2025
Q4 2024 $15.7M -$7.75M -33.1% 31 Dec 2024 10-Q 22 Apr 2025
Q3 2024 $20.1M -$17.9M -47.1% 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $26.4M -$23.6M -47.2% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $28.9M -$31.5M -52.2% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $23.4M -$58.7M -71.5% 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 $38.1M -$38.3M -50.2% 30 Sep 2023 10-K 15 Apr 2024
Q2 2023 $50M +$4.91M +10.9% 30 Jun 2023 10-K 15 Apr 2024
Q1 2023 $60.4M -$2.3M -3.66% 31 Mar 2023 10-K 15 Apr 2024
Q4 2022 $82.1M +$26.9M +48.7% 31 Dec 2022 10-K 15 Apr 2024
Q3 2022 $76.4M +$17.4M +29.5% 30 Sep 2022 10-K 15 Apr 2024
Q2 2022 $45.1M -$25.4M -36% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $62.7M -$10.9M -14.8% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $55.2M -$24.7M -30.9% 31 Dec 2021 10-K 15 Mar 2023
Q3 2021 $59M -$24.7M -29.5% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $70.4M -$1.73M -2.4% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $73.6M -$10.6M -12.5% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $79.9M -$4.62M -5.46% 31 Dec 2020 10-K 15 Mar 2022
Q3 2020 $83.6M +$7.43M +9.75% 30 Sep 2020 10-Q 04 Nov 2020
Q2 2020 $72.2M -$32.7M -31.2% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $84.2M -$31.8M -27.4% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $84.5M -$71.2M -45.7% 31 Dec 2019 10-K 23 Mar 2021
Q3 2019 $76.2M -$72.7M -48.8% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $105M -$46.9M -30.9% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $116M +$44.7M +62.7% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $156M +$76.5M +96.6% 31 Dec 2018 10-K 11 Mar 2020
Q3 2018 $149M 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $152M 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $71.3M 31 Mar 2018 10-Q 07 Jun 2018
Q4 2017 $79.2M 31 Dec 2017 10-K 06 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.